InvestorsHub Logo
icon url

skitahoe

07/14/24 2:36 PM

#705983 RE: drugrunner #705927

What you say has some truth, but by itself it's not curative. Our vaccine makes other products work better, some of those products already come from BP's, in the future I suspect more will be developed or acquired by BP's. In short, as patients live longer, and ideally are cured, they will potentially spend more on products from BP, rather than spending less. Certainly some products which are used today may no longer be used if they have no benefit when using DCVax-L, but others will replace them in making the vaccine more effective, and hopefully leading to cures in many cancers.

Gary
icon url

Karlchen

07/15/24 8:09 AM

#706069 RE: drugrunner #705927

yes, thats to be expected. and, by the way - the price of about 200K for DCVax in the first months will come down, bit by bit on itself (over the years) and , of course much more and faster with flashworks.

All the naysayers about " too high for the treatment " - IOVA - also a good therapie (TIL) costs near of 500K ! ! !